^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CART-30

i
Other names: CAR-T CD30, CART-30, CD30 chimeric antigen receptor T cell therapy
Company:
AbelZeta Pharma, Chinese PLA General Hospital
Drug class:
CD30-targeted CAR-T immunotherapy